Endocrine-Disrupting Chemicals Found in Breast Milk and Infant Urine up to Age 6 Months

Why It Matters

The pervasive presence of EDCs in early nutrition highlights a critical public‑health risk, potentially affecting neurodevelopment and metabolic health. Prompt regulatory and consumer actions are needed to protect infants during this vulnerable exposure window.

Key Takeaways

• BPA found in ~50% of breast milk at 1 and 6 months
• Phthalates present in over 90% of early breast milk
• Infant urine BPA levels rose to 68% by six months
• Parabens detected in >50% of breast milk, increasing over time
• Italian stakeholders sign agreements to monitor and reduce EDCs

Pulse Analysis

The ENDO 2026 presentation of the LIFE‑MILCH project marks one of the most comprehensive assessments of endocrine‑disrupting chemicals in early life nutrition. By sampling breast milk and infant urine at one, three and six months, researchers captured a dynamic exposure profile across more than 50 compounds, from bisphenols to pyrethroids. The data reveal that chemicals once thought to be marginal—such as bisphenol S and certain parabens—are consistently present, while ubiquitous phthalates dominate the contaminant landscape. This granular timeline underscores how infant exposure escalates as product use and dietary patterns evolve in the first half‑year.

Beyond the raw prevalence numbers, the study raises alarm over the biological plausibility of long‑term harm. Prior epidemiological work links prenatal and early postnatal EDC exposure to altered hormone signaling, cognitive deficits, and increased obesity risk. The observed rise in urinary BPA and phthalate metabolites aligns with mechanisms that can disrupt thyroid function and androgen pathways during a critical developmental window. As infants rely exclusively on breast milk, the findings suggest that maternal lifestyle choices and product formulations directly shape the infant’s endocrine environment, potentially imprinting health trajectories that persist into adulthood.

In response, Italian health authorities and industry groups have launched a prevention campaign, committing to tighter product monitoring and formulation changes. The agreements aim to reduce EDC concentrations in cosmetics, plastics and agricultural inputs, reflecting a growing regulatory momentum seen globally. For clinicians and policymakers, the study offers actionable evidence: promoting EDC‑free alternatives, enhancing consumer education, and integrating exposure screening into pediatric care could mitigate risks. As the scientific community continues to map exposure‑outcome pathways, coordinated public‑health strategies will be essential to safeguard the nutritional sanctity of breast milk and the health of the next generation.